These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 14769730)

  • 1. The utility of 99mTc depreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer.
    Kahn D; Menda Y; Kernstine K; Bushnell D; McLaughlin K; Miller S; Berbaum K
    Chest; 2004 Feb; 125(2):494-501. PubMed ID: 14769730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tc-99m depreotide SPECT/CT for lymph node staging of non-small-cell lung cancer.
    Apostolopoulos DJ; Koletsis EN; Spyridonidis T; Paschali A; Papandrianos N; Stamou E; Vassilakos PJ; Dougenis D
    Ann Nucl Med; 2014 Jun; 28(5):463-71. PubMed ID: 24668640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
    Hsia TC; Shen YY; Yen RF; Kao CH; Changlai SP
    Neoplasma; 2002; 49(4):267-71. PubMed ID: 12382027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninferiority of
    Dai D; Rollo FD; Bryant J; Kim EE
    Contrast Media Mol Imaging; 2018; 2018():8969714. PubMed ID: 29736155
    [No Abstract]   [Full Text] [Related]  

  • 5. A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodules.
    Blum J; Handmaker H; Lister-James J; Rinne N
    Chest; 2000 May; 117(5):1232-8. PubMed ID: 10807805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma.
    Poncelet AJ; Lonneux M; Coche E; Weynand B; Noirhomme P;
    Eur J Cardiothorac Surg; 2001 Sep; 20(3):468-74; discussion 474-5. PubMed ID: 11509265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of positron emission tomography for lung cancer staging.
    Albes JM; Dohmen BM; Schott U; Schülen E; Wehrmann M; Ziemer G
    Eur J Surg Oncol; 2002 Feb; 28(1):55-62. PubMed ID: 11869015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The solitary pulmonary nodule--is it malignant or benign? Diagnostic performance of Tc-depreotide SPECT.
    Naalsund A; Maublant J
    Respiration; 2006; 73(5):634-41. PubMed ID: 16679755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F-18-2-fluoro-2-deoxyglucose positron emission tomography compared to technetium-99m hexakis-2-methoxyisobutyl isonitrile single photon emission chest tomography in the diagnosis of indeterminate lung lesions.
    Santini M; Fiorelli A; Vicidomini G; Laperuta P; Busiello L; Rambaldi PF; Mansi L; Rotondo A
    Respiration; 2010; 80(6):524-33. PubMed ID: 20881375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group.
    Vansteenkiste JF; Stroobants SG; De Leyn PR; Dupont PJ; Verschakelen JA; Nackaerts KL; Mortelmans LA
    Chest; 1997 Dec; 112(6):1480-6. PubMed ID: 9404742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99mTc-depreotide scintigraphy versus 18F-FDG-PET in the diagnosis of radioiodine-negative thyroid cancer.
    Rodrigues M; Li S; Gabriel M; Heute D; Greifeneder M; Virgolini I
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3997-4000. PubMed ID: 16895961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of (99m)Tc-depreotide (Neospect) scintigraphy in lung cancer staging.
    Karathanos E; Datseris I; Vlontzou E; Zisimopoulos A; Georgiou E
    J BUON; 2010; 15(1):147-52. PubMed ID: 20414943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of radiologically indeterminate lung lesions: 99mTc-depreotide SPECT versus 18F-FDG PET.
    Ferran N; Ricart Y; Lopez M; Martinez-Ballarin I; Roca M; Gámez C; Carrerea D; Guirao S; Leon AF; Martin-Comin J
    Nucl Med Commun; 2006 Jun; 27(6):507-14. PubMed ID: 16710105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer.
    Berlangieri SU; Scott AM; Knight SR; Fitt GJ; Hennessy OF; Tochon-Danguy HJ; Clarke CP; McKay WJ
    Eur J Cardiothorac Surg; 1999 Sep; 16 Suppl 1():S25-30. PubMed ID: 10536941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study.
    Kim BT; Lee KS; Shim SS; Choi JY; Kwon OJ; Kim H; Shim YM; Kim J; Kim S
    Radiology; 2006 Nov; 241(2):501-9. PubMed ID: 16966480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules.
    Halley A; Hugentobler A; Icard P; Porret E; Sobrio F; Lerochais JP; Bouvard G; Zalcman G; Agostini D
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1026-32. PubMed ID: 15877227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
    Aquino SL; Fischman AJ
    Chest; 2004 Sep; 126(3):755-60. PubMed ID: 15364753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer.
    Kelly RF; Tran T; Holmstrom A; Murar J; Segurola RJ
    Chest; 2004 Apr; 125(4):1413-23. PubMed ID: 15078754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative impact of standard approach, FDG PET and FDG dual-head coincidence gamma camera imaging in preoperative staging of patients with non-small-cell lung cancer.
    Delahaye N; Crestani B; Rakotonirina H; Lebtahi R; Sarda L; Girard P; Charpentier E; Fery-Lemonnier E; Syrota A; Aubier M; Le Guludec D
    Nucl Med Commun; 2003 Dec; 24(12):1215-24. PubMed ID: 14627847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.